Genome-wide association studies (GWAS) in Alzheimer's Disease (AD) have identified polymorphisms in two other genes encoding proteins associated with the complement system, complement receptor 1 (CR1; CD35) and clusterin, that independently influence risk of developing AD [54,55]. The gene discussed is CR1; the disease is early-onset autosomal dominant Alzheimer disease.